In some embodiments, local otic delivery of the auris formulations or compositions described herein allows for controlled release of active agents to auris structures and overcomes the drawbacks associated with systemic administration (e.g., low bioavailability of the drug in the endolymph or perilymph, variability in concentration of the drug in the external, middle and/or internal ear)
Managing stress through evidence-based approaches (regular exercise, meditation, social connection, time in nature) reduces the baseline inflammatory burden that peptide protocols must overcome
Researchers study GHK-Cu in laboratory models to examine its relationship with: .Cellular antioxidant systems .Reactive oxygen species (ROS) .Copper-dependent enzymes .Oxidative biomarkers .Cellular stress responses This research helps scientists explore the complex relationship between oxidative processes and tissue biology
Angiogenesis & Matrix: Both peptides studied for capillary density/neo-vessel formation and ECM organization under injury stressors
Recommended Dosing: Special Notes: BPC-157 can be delivered via subcutaneous injections for musculoskeletal healing or oral formulations for targeted gut support, depending on the clinical goals